Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Ethical considerations in apathy syndromes.

Krupp BH.

Psychiatr Ann. 1997 Jan;27(1):50-4. No abstract available.

PMID:
15739287
2.

An inventory for measuring depression.

BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J.

Arch Gen Psychiatry. 1961 Jun;4:561-71. No abstract available.

PMID:
13688369
3.

The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico.

Ringman JM, Diaz-Olavarrieta C, Rodriguez Y, Fairbanks L, Cummings JL.

Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):99-105.

PMID:
12050472
4.

Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease.

Isella V, Melzi P, Grimaldi M, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I.

Mov Disord. 2002 Mar;17(2):366-71.

PMID:
11921125
5.

The use of pramipexole in Parkinson's disease: are its actions D(3) mediated?

Guttman M, Jaskolka J.

Parkinsonism Relat Disord. 2001 Jul;7(3):231-234.

PMID:
11331191
6.

Ventral striatal D(3) receptors and Parkinson's Disease.

Joyce JN, Ryoo H, Gurevich EV, Adler C, Beach T.

Parkinsonism Relat Disord. 2001 Jul;7(3):225-230.

PMID:
11331190
7.

Family, Alzheimer's disease and negative symptoms.

Thomas P, Clément JP, Hazif-Thomas C, Léger JM.

Int J Geriatr Psychiatry. 2001 Feb;16(2):192-202.

PMID:
11241725
8.

Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease.

Aarsland D, Cummings JL, Larsen JP.

Int J Geriatr Psychiatry. 2001 Feb;16(2):184-91.

PMID:
11241724
9.

Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

Aarsland D, Litvan I, Larsen JP.

J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):42-9.

PMID:
11207328
10.
11.

Relationships among apathy, depression, and cognitive impairment in HIV/AIDS.

Rabkin JG, Ferrando SJ, van Gorp W, Rieppi R, McElhiney M, Sewell M.

J Neuropsychiatry Clin Neurosci. 2000 Fall;12(4):451-7.

PMID:
11083161
12.

Negative symptoms: the 'pathology' of motivation and goal-directed behaviour.

Brown RG, Pluck G.

Trends Neurosci. 2000 Sep;23(9):412-7. Review.

PMID:
10941190
13.

Visual dysfunction in Parkinson's disease.

Rodnitzky RL.

Clin Neurosci. 1998;5(2):102-6. Review.

PMID:
10785835
14.

Cholinesterase inhibitors: A new class of psychotropic compounds.

Cummings JL.

Am J Psychiatry. 2000 Jan;157(1):4-15. Review.

PMID:
10618007
15.

Dot probe performance in two specific phobias.

Wenzel A, Holt CS.

Br J Clin Psychol. 1999 Nov;38 ( Pt 4):407-10.

PMID:
10590828
16.

Range of neuropsychiatric disturbances in patients with Parkinson's disease.

Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings JL.

J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):492-6.

17.

Neuropsychological correlates of apathy and depression in patients with dementia.

Kuzis G, Sabe L, Tiberti C, Dorrego F, Starkstein SE.

Neurology. 1999 Apr 22;52(7):1403-7.

PMID:
10227625
19.

At which steps of spatial working memory processing do striatofrontal circuits intervene in humans?

Le Bras C, Pillon B, Damier P, Dubois B.

Neuropsychologia. 1999 Jan;37(1):83-90.

PMID:
9920474
20.

Caregiver burden at 1 year following severe traumatic brain injury.

Marsh NV, Kersel DA, Havill JH, Sleigh JW.

Brain Inj. 1998 Dec;12(12):1045-59.

PMID:
9876864

Supplemental Content

Support Center